Ikarian Capital, LLC Zymeworks Inc. Put Options Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2021

May 17, 2021
SELL
$29.83 - $56.81 $17.3 Million - $33 Million
-580,200 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$39.12 - $54.99 $13.1 Million - $18.4 Million
335,200 Added 136.82%
580,200 $27.4 Million
Q3 2020

Nov 16, 2020
BUY
$29.21 - $46.58 $940,562 - $1.5 Million
32,200 Added 15.13%
245,000 $11.4 Million
Q2 2020

Aug 14, 2020
BUY
$33.67 - $40.0 $7.16 Million - $8.51 Million
212,800 New
212,800 $7.68 Million

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $949M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email